← Eichor
Condition: Multiple Sclerosis Relapsing Remitting Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Multiple Sclerosis Relapsing Remitting

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
NA · 1 location(s) · Cionic, Inc. · NCT05964829A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of a New Subcuta
Phase 1 · 12 location(s) · Hoffmann-La Roche · NCT07667322Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
Phase 4 · 1 location(s) · Northwestern University · NCT07225361Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis
Phase N/A · 1 location(s) · Shirley Ryan AbilityLab · NCT06516458Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
Phase 3 · 22 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT04047628Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis
Phase 2 · 1 location(s) · Ari Green · NCT07510607Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS
Phase 3 · 1 location(s) · Amsterdam UMC, location VUmc · NCT05834855Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis
NA · 1 location(s) · Georgia State University · NCT06919900Retinal Neuro-vascular Coupling in Patients With Multiple Sclerosis
NA · 1 location(s) · Medical University of Vienna · NCT03401879"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
Phase N/A · 1 location(s) · University of California, San Francisco · NCT07222618Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS
NA · 1 location(s) · Shirley Ryan AbilityLab · NCT06390930Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT05177523Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relap
Phase 3 · 33 location(s) · Bristol-Myers Squibb · NCT06408259Understanding the 'Durable Effect' Concept of B-cell Modulating Therapies
Phase N/A · 1 location(s) · Heinrich-Heine University, Duesseldorf · NCT06586177Fatigue Alleviation Through Neuromodulating Therapy in Multiple Sclerosis
NA · 1 location(s) · Danish Research Centre for Magnetic Resonance · NCT06569550MS-ResearchBiomarkerS
Phase N/A · 1 location(s) · Cedars-Sinai Medical Center · NCT05204459Biomarkers of aHSCT
Phase N/A · 1 location(s) · Sheffield Teaching Hospitals NHS Foundation Trust · NCT06195800ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS
Phase 4 · 14 location(s) · Novartis Pharmaceuticals · NCT06733922Definition of Autonomic Nervous System Involvement in Patients With Multiple Sclerosis
NA · 2 location(s) · Istituti Clinici Scientifici Maugeri SpA · NCT05748015Deuterium Metabolic Imaging in People with Multiple Sclerosis
Phase N/A · 1 location(s) · University of Aarhus · NCT06611280RRMS: Disease PROgression and Myeloid Profiling After Bone Marrow TRANSPLANTation and Second Line Therapies
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06267781Light Stimulation to Improve Visual Function After Optic Neuritis in Persons with Multiple Sclerosis
NA · 1 location(s) · Technical University of Munich · NCT06389968Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study
NA · 2 location(s) · University of Florida · NCT07376772Combined Motor Imagery and Vestibular Rehab for MS
NA · 1 location(s) · Medipol University · NCT07230015Multiple Sclerosis and the Effects of Ketogenic Diet Therapy
NA · 1 location(s) · IRCCS National Neurological Institute "C. Mondino" Foundatio · NCT06715436Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis
Phase 4 · 6 location(s) · Novartis Pharmaceuticals · NCT04480853RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.
Phase 3 · 23 location(s) · Rennes University Hospital · NCT05758831Intermittent Hypoxia in Persons With Multiple Sclerosis
NA · 1 location(s) · Shirley Ryan AbilityLab · NCT06276634Sexual Dysfunction in Women With Multiple Sclerosis (MS)
Phase N/A · 1 location(s) · Ege University · NCT07193823A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsin
Phase 3 · 1 location(s) · University Hospital, Montpellier · NCT07189325
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.